Our specialized units cover diverse therapeutic areas such as endocrinology, metabolic disorders, cardiology, gastroenterology, women’s health, dermatology, hematology, and nephrology.
We are at the forefront of cutting-edge research into blood coagulation mechanisms and pharmacological interventions. Our studies focus on uncovering critical insights that pave the way for improved treatment options and patient outcomes.
With decades of specialized experience in hemostaseology, we excel in areas such as single ascending dose (SAD), multiple ascending dose (MAD), investigations into drug and food interactions, bioavailability, and bioequivalence.
As your trusted partner in hemostaseology, we maintain the highest standards of quality and precision in clinical research. Our specialized team ensures accurate and timely processing of a diverse range of samples, continually enhancing our medical diagnostic methods to provide tailored solutions that meet your specific clinical trial requirements. Our capabilities include bleeding time assessments like Surgicutt, bedside monitoring with Hemochron© for activated partial thromboplastin time (aPTT), partial thromboplastin time with kaolin, and thrombocyte aggregation studies.
Contact us today to learn how we can advance your clinical research in hemostaseology, ensuring patient safety and pioneering new treatment possibilities.